Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06312813 · ClinicalTrials.gov registry record · Phase 2

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

A Phase 2 study of Rosacea, sponsored by Wright State University.

Recruiting
Registry status
Phase 2
Development phase
48
Enrollment target
1
Study location

NCT06312813 is a Phase 2 study of Rosacea that is actively recruiting participants, run by Wright State University. The registered enrollment target is 48 participants, below the 241-participant average among 23 other Rosacea trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06312813, a Phase 2 study of Rosacea, is actively recruiting participants, sponsored by Wright State University.

RECRUITING
Registry status
Phase 2
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.

Conditions Studied

Rosacea

Interventions

  • DRUG Amitriptyline
  • DRUG Imipramine
  • DRUG Vehicle

Study Locations (1)

Ohio

  • Wright State Physicians - Fairborn

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2024-02-27
Est. Completion 2028-12-01
Phase Phase 2

Sponsor

Wright State University

32 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06312813

The ClinicalTrials.gov registry entry for NCT06312813 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 23 other Rosacea trials with a reported enrollment target (80% lower). The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rosacea appearing as the primary indexed condition, and to 3 interventions - of which Amitriptyline is the first listed.

NCT06312813 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06312813 about?

NCT06312813 is a clinical study titled "Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea". Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with r...

What is the current status of trial NCT06312813?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2024-02-27. Estimated completion is 2028-12-01.

What conditions does trial NCT06312813 study?

This clinical trial studies the following conditions: Rosacea.

What interventions are being tested in trial NCT06312813?

The interventions under investigation include: Amitriptyline (DRUG), Imipramine (DRUG), Vehicle (DRUG).

Who is sponsoring clinical trial NCT06312813?

This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06312813 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rosacea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rosacea

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.